MUMBAI, India, May 08, 2024 –Global healthcare leader Abbott announced the launch of its innovative automation solutions, GLP systems Track, to support laboratories’ high-volume needs. India is now the world’s most populous nation, and the population is experiencing rising chronic disease burden. As a result, the Indian diagnostic sector is expected to grow at a compound annual growth rate of 11% to 12% between 2021 and 2026.i Abbott’s proven cutting-edge technology offers more flexibility, helping laboratories optimize performance and efficiency to meet this growing demand.
Over the last several years, the need for diagnostic laboratories has increased. Today, up to 70% of medical decisions depend on lab test results.ii Abbott’s GLP systems Track can help increase accessibility and quality of care by automating lab operations. The track has been installed in Chennai’s Neuberg Ehrlich Diagnostics Lab, fulfilling the rapidly growing testing demand in Chennai, which has seen more than 20% growth rate recently. The automation solution has also been installed in Bengaluru, Ahmedabad and Srinagar.
“Today, the healthcare scenario is constantly changing. To remain efficient and competitive, laboratories must elevate their capabilities to effectively manage changing conditions. Our total solution approach addresses every facet of the complex healthcare equation -- with automation at its heart,” said Jamshyd Patravala, General Manager & Country Head – Diagnostics, Abbott India. “This can help increase testing capabilities, thereby addressing the country’s pressing health challenges and creating more sustainable operations.”
With this launch, Abbott aims to strike a balance between quality of care and efficient use of resources. Across different care settings, depending on laboratory size and patient pool, this automation solution can handle bulk test tubes per day. GLP systems Track can help reduce operational costs by more than 50% compared to conventional systems,iii,iv,v supporting system uptime. It also removes at least 80% of manual steps, minimizing manual errors.vi,vii,viii
The automation solution also improves lab workers’ safety by minimizing contact with patients’ blood samples and preventing exposure to biomedical waste.
“Abbott’s GLP systems Track offers us a reliable solution to support efficient workflows . It comes with several benefits, including an agile track design to support wide range of laboratory layouts and giving flexibility to modify in case of changing testing demand. Its simple user interface and smart software architecture support operational efficiency. This helps improve workflow and productivity, helping to ensure physicians receive critical results at the right time to guide clinical decision-making and better patient care,” said Dr. Preeti Kabra, Senior Chief of Laboratory, Neuberg Diagnostics.
Energy efficient technology, such scalable automation solutions, improve end-to-end lab efficiency by streamlining workflow and simplifying sample management. As a result, it improves the quality of service and contributes to a sustainable future while maintaining a small footprint.
About Abbott:
Abbott is a global healthcare leader that helps people live more fully at all stages of life. Our portfolio of life-changing technologies spans the spectrum of healthcare, with leading businesses and products in diagnostics, medical devices, nutritionals and branded generic medicines. Our 115,000 colleagues serve people in more than 160 countries.
In India, Abbott was established in 1910, and is one of the country's oldest and most admired healthcare companies. With more than 12,000 employees in the country, Abbott is helping to meet the healthcare needs of consumers, patients and doctors throughout urban and rural India.
Connect with us at www.abbott.com and www.abbott.in, on Facebook at www.facebook.com/Abbott and www.facebook.com/AbbottIndia, and on Twitter @AbbottNews.
Abbott Media:
Smritee Chaturvedi, smritee.chaturvedi@abbott.com
References:
iHDFC Securities (March 2021). Initiating Coverage – Diagnostics Sector: Retail Research Report: https://www.hdfcsec.com/hsl.research.pdf/Diagnostics%20Sector%20-%20Initiating%20Coverage%20v2%20-%2030.03.2021.pdf.
iihttps://www.cdc.gov/csels/dls/strengthening-clinical-labs.html
iiihttps://manualzz.com/doc/55433857/roche-cobas-p-612-operators-manual
ivhttps://www.beckmancoulter.com/download/wsr-211873?type=pdf
vhttps://www.siemens-healthineers.com/en-in/laboratory-automation/systems/aptio-automation
vihttps://manualzz.com/doc/55433857/roche-cobas-p-612-operators-manual
viihttps://www.beckmancoulter.com/download/wsr-211873?type=pdf
viiihttps://www.siemens-healthineers.com/en-in/laboratory-automation/systems/aptio-automation
Links which take you out of Abbott worldwide websites are not under the control of Abbott, and Abbott is not responsible for the contents of any such site or any further links from such site. Abbott is providing these links to you only as a convenience, and the inclusion of any link does not imply endorsement of the linked site by Abbott.
The website that you have requested also may not be optimized for your screen size.
FOLLOW ABBOTT